VIM and endometrial cancer: Vimentin expression in preoperative samples from 1483 women diagnosed with endometrial cancer was evaluated by immunohistochemistry using a staining index (SI), ranging from strong expression (SI 9) to loss of expression (SI 0) (Fig. 1a).